Amaç: Bu çalışmada total diz artroplastisi (TDA) hastalarında eklem içi tranekzamik asit (TA) uygulamasının drenlerdeki kan miktarına, kan transfüzyonu miktarına, hastanede kalış süresine ve toplam maliyete etkisi değerlendirildi. Hastalar ve yöntemler: Çalışmaya TDA cerrahisi uygulanan toplam 118 hasta dahil edildi (24 erkek, 94 kadın; ort. yaş 67.0; dağılım 52-81 yıl). Hastalar eklem kapsülünün kapatılmasının ardından eklem içi 2 g TA uygulanan 58 hasta (TA grubu; 10 erkek, 48 kadın ort. yaş 65.6; dağılım 55-80 yıl) ve herhangi bir eklem içi enjeksiyon uygulanmayan 60 hasta (TA'sız grup; 14 erkek, 46 kadın; ort. yaş 68.3; dağılım 52-81 yıl) olarak iki gruba ayrıldı. Her hastanın ameliyat öncesi ve sonrası hemoglobin düzeyleri arasındaki maksimum farklılık, drenlerdeki kan miktarı, kan transfüzyonu miktarı, hastanede kalış süresi ve maliyeti kaydedildi. Bulgular: Ameliyat öncesi ve sonrası hemoglobin düzeylerindeki ortalama farklılık TA'sız grupta daha yüksek idi (1.7 g/dL'ye karşın 2.6 g/dL, p<0.05). Drenlerdeki ortalama kan miktarları (327.5 mL'ye karşın 800.0 mL, p<0.05), kan transfüzyonu miktarları (0 üniteye karşın 10 ünite, p<0.05), ortalama hastanede kalış süreleri (4.03 güne karşın 4.53 gün, p<0.05) ve hastane maliyetleri (1.935,26 Amerika Birleşik Devletleri dolarına karşın 1.959,64 Amerika Birleşik Devletleri doları, p<0.05) TA grubunda daha düşük idi. Sonuç: Primer TDA sırasında eklem içi TA uygulaması kan kaybını ve kan transfüzyonu gereksinimini azaltırken ameliyat sonrası hastanede kalış sürelerini kısaltıp toplam hastane maliyetlerini anlamlı şekilde azaltabilmektedir.
The number of total knee arthroplasty (TKA) surgeries has been increasing. [1] Blood loss is one of the well-known complications of this procedure which can lead to long hospital stay, postoperative morbidity, and delay in postoperative rehabilitation of the patients. [2, 3] Antifibrinolytic medications, such as tranexamic acid (TA), have been used in elective orthopedic surgeries perioperatively to reduce the bleeding and also blood transfusions. [4] Topical use of TA has been becoming popular recently as it has the advantages of being easy to administer, providing a maximum concentration at the bleeding site, and inducing partial microvascular hemostasis by stopping fibrin clot dissolution in the affected area. Some studies about topical administration of TA showed reliable evidence that it was effective in reducing total blood loss and blood transfusion rate compared with the placebo [5] [6] [7] [8] [9] and also intravenous (IV) administrations. Topical use of TA has been shown to reduce postoperative swelling, leading to improved wound healing, reduced pain, and more rapid rehabilitation. [5, 7] Up to date, limited number of publications has been published about effects of topical use of TA on the length of hospital stay and the total cost due to knee arthroplasty. [10, 11] Therefore, in this study, we aimed to evaluate the effect of intra-articular TA administration on the amount of blood in the drains, the amount of blood transfusion, length of hospital stay, and the total cost in TKA patients. Standard Hemovac drains (B-Vak 400 mL Wound Drainage System 14 CH, Bıçakcılar Tıbbi Cihazlar San. ve Tic. A.Ş., İstanbul, Turkey) were used for all patients. Tourniquets were released after the application of compressive dressings in all patients. The clamps of the drains were opened 30 minutes postoperatively and removed 24 hours later. All patients received enoxaparin as prophylaxis against deep vein thrombosis 12 hours preoperatively and the next injection was at eight hours postoperatively.
PATIENTS AND METHODS

This
A transfusion threshold of hemoglobin 8 g/dL was routinely utilized. Also, the patients who had hemoglobin levels between 8 g/dL and 10 g/dL with hypotension symptoms were considered for blood transfusion as published in previous papers. [2, 7] The patients were discharged when they were mobile independently, had no pain complaint, and had dry wound after they had active 90 degrees knee flexion and full extension. Standard follow-up visits were performed for all patients by the orthopedic surgeons in the clinic at postoperative 15 th day, and sixth and 12 th weeks. Data on clinical and surgical characteristics as well as complications (such as deep vein thrombosis, pulmonary embolism, and wound infection) were obtained from electronic medical records.
Cost data were obtained from an institutional cost and utilization database that contained standardized cost of each service or procedure provided to patients by Selçuk University Medical Faculty Hospital in constant Turkish Liras (TL). At the end of the study duration, 1 US dollar was 2.67 TL (June 1 st , 2015).
The maximum difference between pre-and postoperative hemoglobin levels, amount of blood in the drains, amount of blood transfusion, length of hospital stay, and cost of each patient to the hospital were documented.
Statistical analysis
All statistical analyses were performed using IBM SPSS version 20.0 software (IBM Corp., Armonk, NY, USA). Binary conditions, such as gender, were compared using Pearson chi-square and Fisher's exact tests. Continuous factors, such as age and body mass index, were compared with Independent t-test if the distributions were stochastically ordered. Benefits of tranexamic acid in total knee arthroplasty Mann-Whitney U test was used for distributions that were not stochastically ordered. Statistical significance was defined as a p value of <0.05.
RESULTS
There were no statistically significant differences in demographic characteristics between the TA and non-TA groups except the age parameter. TA group was statistically older by 2.7 years (68.4 years vs 65.7 years p<0.05) than non-TA group (Table I) . Body mass indices were similar (32.89 kg/m 2 vs 31.7 kg/m 2 , p=0.23).
The mean difference between the pre-and postoperative hemoglobin levels was significantly higher in the non-TA group (1.7 g/dL vs 2.6 g/dL, p<0.05). The mean amount of blood in drains, the need of blood transfusions, the mean length of hospital stay, and the total hospital cost of patients were shown in Table II. Ten patients (17%) of the non-TA group required blood transfusion compared to none in the TA group. Eight patients required two, and two patients required one unit of blood transfusions. The comparison of the groups according to the need of blood transfusion was statistically significant (p<0.005).
The mean length of hospital stay was significantly shorter in TA group although the mean difference was shorter than one day (4.03 days vs 4.53 days). The total hospital cost of the patients in TA group was significantly lower compared to the non-TA group patients.
Three patients (one in TA and two in non-TA groups) readmitted to hospital secondary to wound discharge, which was continuing for ten days postoperatively. All of them were hospitalized for detailed follow-up and wound dressings for three more days. No medication was given to the patients during their second hospitalization. The second hospitalization period was added to their previous length of hospital stay. Complaints were relieved in three days after the readmissions. None of the patients had complaints related to anemia or thromboembolic events during their follow-up visits. There was no rehospitalization history among (1,959.64 USD) . The cost was significantly lower in TA group (p<0.05). The implant cost was unique, 3,708.00 TL, for all the patients, which is determined by Turkish Health Security System. The remaining cost includes all hospitalization costs other than the implant cost.
DISCUSSION
There is no consensus about the amount and the method for topical administration of TA in arthroplasty patients. [5] [6] [7] [8] [9] [10] 12, 13] The patients in this study received 2 g TA intraarticularly at the end of the surgery before the skin closure similar to the previous published papers [5, 13] while the others did not receive any antifibrinolytics.
The mean amount of blood in drains was 430 mL lower in TA group. As we performed all the surgeries under tourniquet, the amount of blood in the drains can be suggestive about the perioperative bleeding. Also, the hemoglobin difference between pre-and postoperative values was significantly lower in TA group. This result also supports the affectivity of topical TA in knee arthroplasty patients. None of the patients required blood transfusion in TA group although 10 of the 60 patients in non-TA group required a total of 18 units of blood transfusion.
Of the total hospital costs, 3,708.00 TL (1,388.76 USD) is the implant cost which is standard for all the patients. The anesthesia and operating room costs were between 400 TL -800 TL (150 USD -301 USD) according to spinal or general anesthesia. In the literature, similar studies were reported about the cost-effectiveness of IV use of TA in arthroplasty surgeries. [2, 4] To our knowledge, this is the third study about the effect of topical TA on the hospital cost in knee arthroplasty surgery. However, our administration method was different from the previous studies as we applied TA intraarticularly after the closure of joint capsule. Topical TA application may have a positive effect on providing fast recovery as suggested by the significantly shorter length of hospital stay compared to non-TA group. This study has some limitations. First, this is a nonblind retrospective study from a single institution using a prospective database. A prospective doubleblind study would be a superior method to track all the patients' cost with longer follow-up period.
The separation of related factors such as length of hospital stay and the cost could not be made due to the retrospective design. Furthermore, we used 2 g TA diluted in 25 mL saline which can be considered as a concentrated solution. There is no consensus about the dose and the concentration for the intra-articular use of TA. Also, we do not know clearly the chemical side effects of intra-articular TA use. We believe that more studies are needed to evaluate the dose-related chemical side effects for intra-articular administration of TA. Certainly, the single-institution results cannot be generalized to other institutions. Another limitation is the short follow-up time. Controlled prospective studies with longer follow-up periods are needed for analyzing the main complications of primary knee arthroplasty such as infection and thromboembolic events with the use of topical TA. Also, the control group patients were older by 2.7 years and the surgeons of the groups were different. This limitation was minimalized by limiting the patient population to healthy patients (maximum ASA class II, similar body mass index, and gender).
In conclusion, single dose topical application of TA may have positive effects on knee arthroplasty patients by reducing the need of blood transfusion, shortening the postoperative length of hospital stay, and also reducing the total hospital costs. However, further prospective controlled clinical studies are needed to support these findings.
